MXPA03011924A - Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. - Google Patents

Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.

Info

Publication number
MXPA03011924A
MXPA03011924A MXPA03011924A MXPA03011924A MXPA03011924A MX PA03011924 A MXPA03011924 A MX PA03011924A MX PA03011924 A MXPA03011924 A MX PA03011924A MX PA03011924 A MXPA03011924 A MX PA03011924A MX PA03011924 A MXPA03011924 A MX PA03011924A
Authority
MX
Mexico
Prior art keywords
mycoplasma
vaccine
cattle
methods
reducing
Prior art date
Application number
MXPA03011924A
Other languages
English (en)
Inventor
Crossan Goudie Alexander
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA03011924A publication Critical patent/MXPA03011924A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se refiere a metodos para tratar o prevenir una enfermedad o trastorno en un animal causado por infeccion con Mycoplasma bovis (M. bovis) mediante la administracion al animal de una cantidad eficaz de una vacuna de Mycoplasma hyopneumoniae (M, hyo); la vacuna de M. hyo puede ser una preparacion de celulas totales o parciales de celulas vivas inactivadas o modificadas, una vacuna de subunidades o una vacuna de acidos nucleicos o ADN; la vacuna de M. hyo administrada de acuerdo con la presente invencion se puede sintetizar o producir de forma recombinante.
MXPA03011924A 2001-07-02 2002-05-30 Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado. MXPA03011924A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30258601P 2001-07-02 2001-07-02
PCT/IB2002/001937 WO2003004051A2 (en) 2001-07-02 2002-05-30 Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle

Publications (1)

Publication Number Publication Date
MXPA03011924A true MXPA03011924A (es) 2004-03-26

Family

ID=23168382

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011924A MXPA03011924A (es) 2001-07-02 2002-05-30 Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.

Country Status (9)

Country Link
US (1) US7056492B2 (es)
EP (1) EP1521592A2 (es)
JP (1) JP2004537543A (es)
CN (1) CN1612749A (es)
AR (1) AR034677A1 (es)
BR (1) BR0211049A (es)
CA (1) CA2452666A1 (es)
MX (1) MXPA03011924A (es)
WO (1) WO2003004051A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040031015A (ko) * 2001-08-28 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 보비스 시험감염 모델, 엠. 보비스 투여방법 및 폐렴성 폐 병변 유도 방법
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
MX2010005014A (es) 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
NZ602945A (en) * 2008-06-27 2014-05-30 Zoetis Llc Novel adjuvant compositions
EP2362780B1 (en) 2008-10-31 2019-12-25 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
MX2011012362A (es) * 2009-05-19 2012-04-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
US9539209B2 (en) 2009-06-04 2017-01-10 National Institute Of Infectious Diseases Vaccine for mycoplasma infection
WO2012084951A1 (en) * 2010-12-22 2012-06-28 Bayer Animal Health Gmbh Enhanced immune response in bovine species
MX362166B (es) * 2012-03-07 2018-12-14 Ceva Sante Animale Nueva vacuna veterinaria.
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
WO2014105672A1 (en) 2012-12-28 2014-07-03 Boehringer Ingelheim Vetmedica Gmbh Method of making a mycoplasma vaccine
EA038206B1 (ru) * 2012-12-28 2021-07-23 Бёрингер Ингельхайм Ветмедика Гмбх Иммуногенная композиция, содержащая антигены микоплазм
WO2015035474A1 (en) * 2013-09-16 2015-03-19 The University Of Melbourne Serological test
CN109675026A (zh) 2013-09-19 2019-04-26 硕腾服务有限责任公司 油基佐剂
CN105792841B (zh) 2013-11-21 2019-07-26 财团法人农业科技研究院 防治霉浆菌感染的组合物
JP6772065B2 (ja) 2014-02-28 2020-10-21 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ａｎｉｍａｌ Ｈｅａｌｔｈ Ｇｍｂｈ 免疫賦活プラスミド
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
SI3244920T1 (sl) 2015-01-16 2023-09-29 The United States of America, represented by The Secretary of Agriculture, United States Department of Agriculture Cepivo proti slinavki in parkljevki
US10279031B2 (en) * 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
CN111856005B (zh) * 2020-06-22 2021-07-30 华中农业大学 牛支原体分泌蛋白MbovP280的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0527771A4 (en) * 1990-04-02 1993-05-05 Synergen, Inc. Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures

Also Published As

Publication number Publication date
CN1612749A (zh) 2005-05-04
WO2003004051A3 (en) 2005-02-17
EP1521592A2 (en) 2005-04-13
CA2452666A1 (en) 2003-01-16
US7056492B2 (en) 2006-06-06
WO2003004051A2 (en) 2003-01-16
AR034677A1 (es) 2004-03-03
JP2004537543A (ja) 2004-12-16
BR0211049A (pt) 2004-07-20
US20030064079A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
AP2003002937A0 (en) One dose vaccination with mycoplasma hyopneumoniae
BG108496A (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
RU2008105348A (ru) Вакцина на основе lawsonia и способы ее применения
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BRPI0010612B8 (pt) vacinas
MA27388A1 (fr) Vaccin pour des infections du systeme respiratoire et du systeme reproducteur chez les bovins
MX2008011247A (es) Vacuna de micoplasma hyopneumoniae.
MXPA04001872A (es) Modelo de exposicion a micoplasma bovis, procedimiento para administrar m. bovis y procedimientos para inducir lesiones pulmonares neumonicas.
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
JP5865839B2 (ja) 粘膜アジュバント組成物
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
RU2775580C1 (ru) Способ профилактики инфекционного ринотрахеита у телят
RU2240820C2 (ru) Средство для профилактики инфекционного кератоконъюнктивита крупного рогатого скота и способ профилактики этого заболевания
RU2230505C2 (ru) Способ профилактики туберкулеза крупного рогатого скота
Ibrahim et al. Use of Carbopol as an adjuvant in preparation of inactivated rabbit pasteurellosis vaccine
Poot Experimental challenge models for canine leishmaniasis in hamsters and dogs
ES2172482B1 (es) Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania".
MY168662A (en) Attenuated bacteria for use in a vaccine
MY188912A (en) Attenuated bacteria for use in a vaccine
UA12940U (en) Associated inactivated concentrated velshipast vaccine against anaerobic enterotoxicemia and pasteurellosis of animals

Legal Events

Date Code Title Description
FG Grant or registration